| Identification | Back Directory | [Name]
Ganoderenic acid B | [CAS]
100665-41-6 | [Synonyms]
Ganoderenic acid b
(20E)-3β,7β-Dihydroxy-11,15,23-trioxolanosta-8,20(22)-diene-26-oic acid
(20E)-3β,7β-Dihydroxy-11,15,23-trioxo-5α-lanosta-8,20(22)-dien-26-oic acid
(3beta,7beta,20E)-3,7-Dihydroxy-11,15,23-trioxolanosta-8,20(22)-dien-26-oic acid | [Molecular Formula]
C30H42O7 | [MDL Number]
MFCD32633549 | [MOL File]
100665-41-6.mol | [Molecular Weight]
514.65 |
| Hazard Information | Back Directory | [Description]
Ganoderenic acid B is a cyclic peptide that belongs to the group of chemical substances. It is an immunomodulator and an anti-cancer agent. Ganoderenic acid B is a monoclonal antibody (mAb) against the surface methodology of cancer cells. It has been shown to have significant cytotoxicity in cell culture, as well as in animal models of cervical cancer. Ganoderic acid B has also been shown to inhibit multidrug resistance in cancer cells, which may be due to its ability to inhibit the polymerase chain reaction (PCR). | [Uses]
Doxylamine (succinate) (Standard) is the analytical standard of Doxylamine (succinate). This product is intended for research and analytical applications. Doxylamine (succinate), a first generation antihistamine, is a histamine (H1) receptor antagonist. Doxylamine is also a local analgesic agent and effective hypnotic agent. | [Definition]
ChEBI: Ganoderenic acid B is a triterpenoid. |
|
|